retinol has been researched along with Pituitary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, S; Li, B; Li, S; Shen, R; Tang, X; Yang, H; Yin, H; Zang, Z; Zheng, X | 1 |
| Aranda, A; Pascual, A; Pérez, P; Sánchez-Pacheco, A | 1 |
2 other study(ies) available for retinol and Pituitary Neoplasms
| Article | Year |
|---|---|
Potential biomarkers and lncRNA-mRNA regulatory networks in invasive growth hormone-secreting pituitary adenomas.
Topics: Adolescent; Adult; Biomarkers; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 12; Cytochrome P-450 Enzyme System; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Growth Hormone-Secreting Pituitary Adenoma; Humans; Male; Metabolic Networks and Pathways; Middle Aged; Pituitary Neoplasms; RNA, Long Noncoding; RNA, Messenger; Smell; Vitamin A; Xenobiotics | 2021 |
Retinoic acid decreases thyroid hormone receptor expression in pituitary GH1 cells.
Topics: Animals; Cell Line; Etretinate; Isotretinoin; Kinetics; Macromolecular Substances; Pituitary Neoplasms; Poly A; Proto-Oncogene Proteins; Rats; Receptors, Thyroid Hormone; RNA; RNA, Messenger; RNA, Neoplasm; Transcription, Genetic; Tretinoin; Triiodothyronine; Vitamin A | 1991 |